Similarly, TUG1 also enhanced proliferation and metastasis and cisplatin resistance and induced apoptosis of BLCA cells by acting as sponges of miR-194-5p and miR-140-3p [69,70]. Here, TUG1 is linked to bladder transitional cell carcinoma.